Production (Stage)
Acrivon Therapeutics, Inc.
ACRV
$1.17
$0.021.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.06% | 40.82% | 31.93% | 19.60% | -8.52% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.96% | -3.80% | -36.26% | -21.78% | -42.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.94% | 40.05% | 30.79% | 18.97% | -9.54% |
|
|
|||||
| Total Current Assets | 34.94% | 40.05% | 30.79% | 18.97% | -9.54% |
| Net Property, Plant & Equipment | 4.85% | 1.48% | 36.81% | 17.05% | 15.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 141.18% | 177.44% | 348.42% | 117.89% | 97.16% |
| Total Assets | 46.32% | 42.18% | 42.09% | 44.07% | -29.19% |
|
|
|||||
| Total Accounts Payable | 79.52% | -84.98% | 0.13% | -0.47% | 49.64% |
| Total Accrued Expenses | 42.50% | 108.72% | 74.85% | 75.35% | 65.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.06% | 20.52% | 34.02% | 29.88% | 27.57% |
| Total Finance Division Other Current Liabilities | 143.75% | -- | -- | -- | -- |
| Total Other Current Liabilities | 143.75% | -- | -- | -- | -- |
| Total Current Liabilities | 49.87% | 29.40% | 59.36% | 60.81% | 59.12% |
|
|
|||||
| Total Current Liabilities | 49.87% | 29.40% | 59.36% | 60.81% | 59.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.19% | -31.30% | -18.41% | -15.72% | -13.47% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.24% | 16.00% | 37.46% | 33.70% | 28.93% |
|
|
|||||
| Common Stock & APIC | 56.36% | 57.05% | 57.14% | 58.31% | 5.11% |
| Retained Earnings | -63.01% | -69.19% | -79.22% | -83.43% | -93.21% |
| Treasury Stock & Other | 504.29% | 638.55% | 358.94% | 95.55% | -877.78% |
| Total Common Equity | 48.54% | 45.87% | 42.52% | 44.83% | -32.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.54% | 45.87% | 42.52% | 44.83% | -32.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.54% | 45.87% | 42.52% | 44.83% | -32.71% |
|
|
|||||